Haanschoten Marco C, Kreeftenberg Herman G, Arthur Bouwman R, van Straten Albert H M, Buhre Wolfgang F, Soliman Hamad Mohamed A
Department of Anaesthesiology, Catharina Hospital, Eindhoven, The Netherlands; Intensive Care Unit, Catharina Hospital, Eindhoven, The Netherlands.
Intensive Care Unit, Catharina Hospital, Eindhoven, The Netherlands.
J Cardiothorac Vasc Anesth. 2017 Feb;31(1):45-53. doi: 10.1053/j.jvca.2016.04.017. Epub 2016 Apr 22.
In the present study, the authors investigated the predictive value of postoperative peak arterial lactate levels for early and late mortality after cardiac surgery.
Retrospective analysis of prospectively collected data.
Single-center study in an academic hospital.
Adult patients who underwent cardiac surgery between 2004 and 2014 (n = 16,376).
Different cardiac surgical procedures.
Patients were classified according to the peak arterial lactate level (PALL) within 3 days postoperatively. Logistic regression analysis and Cox regression analysis were performed to identify postoperative peak arterial lactate level as a predictor for early and late mortality respectively. In 8460 patients (51.7%), lactate was not measured postoperatively because these patients were managed according to the fast-track protocol. These patients constituted group 1 in our population but were excluded from the regression analysis. The remaining patients (n = 7,916; 48.3%) were divided according to the postoperative peak arterial lactate level (PALL): PALL<5 mmol/L (group 2), PALL 5 to 10 mmol/L (group 3), and PALL of>10 mmol/L (group 4). Early mortality was 3.7%, 20.4%, and 62.9% in groups 2, 3, and 4 respectively (p<0.0001). This mortality rate was significantly higher than that of group 1 (1.6%); p<0.0001. Multivariate regression analyses revealed postoperative peak arterial lactate as a significant predictor of 30-day mortality (odds ratio = 1.44 [1.39-1.48], p<0.001) as well as for late mortality (hazard ratio = 1.05 [1.01-1.10], p<0.025).
Postoperative peak arterial lactate level in patients undergoing cardiac surgery is an independent predictor for both early and late mortality.
在本研究中,作者调查了心脏手术后动脉血乳酸峰值水平对早期和晚期死亡率的预测价值。
对前瞻性收集的数据进行回顾性分析。
一家学术医院的单中心研究。
2004年至2014年间接受心脏手术的成年患者(n = 16376)。
不同的心脏外科手术。
根据术后3天内的动脉血乳酸峰值水平(PALL)对患者进行分类。进行逻辑回归分析和Cox回归分析,分别将术后动脉血乳酸峰值水平确定为早期和晚期死亡率的预测指标。8460例患者(51.7%)术后未测量乳酸,因为这些患者按照快速康复方案进行管理。这些患者在我们的研究人群中构成第1组,但被排除在回归分析之外。其余患者(n = 7916;48.3%)根据术后动脉血乳酸峰值水平(PALL)分为:PALL<5 mmol/L(第2组),PALL 5至10 mmol/L(第3组),PALL>10 mmol/L(第4组)。第2、3、4组的早期死亡率分别为3.7%、20.4%和62.9%(p<0.0001)。该死亡率显著高于第1组(1.6%);p<0.0001。多因素回归分析显示,术后动脉血乳酸峰值是30天死亡率(比值比 = 1.44 [1.39 - 1.48],p<0.001)以及晚期死亡率(风险比 = 1.05 [1.01 - 1.10],p<0.025)的重要预测指标。
心脏手术患者术后动脉血乳酸峰值水平是早期和晚期死亡率的独立预测指标。